Form4insider filings, from the source

SEC Form 4 · accession 0001127602-18-001115

BIOGEN INC. · BIIB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jeffrey D Capello
Officer — EVP & Chief Financial Officer
Period of report
Jan 2, 2018
Accepted (ET)
Jan 4, 2018 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF1$0.00Jan 2, 2018A8,980A—Jan 2, 2021Common Stock8,9808,980D
Performance Stock UnitF2,F3$0.00Jan 2, 2018A5,390A——Common Stock5,3905,390D

Explanation of responses